#London #United Kingdom #Parkinson's Care #Kneu Health #Dementia Monitoring

Kneu Health Secures $5.6 Million to Revolutionize Neurology Care

Kneu Health, a pioneering company dedicated to transforming care in neurology, has announced the successful closure of a $5.6 million seed funding round. This funding, which was oversubscribed and co-led by prestigious institutions such as Oxford Science Enterprises and Cedars-Sinai, aims to propel the company's expansion in the United States. With additional investment from Social Impact Enterprises, JIMCO, G.K. Goh Ventures, and SXSW London, Kneu's total funding has now reached $11.2 million.

The Growing Need for Innovative Neurodegenerative Care

As neurological disorders become an increasingly pressing public health concern, with Parkinson's disease recognized as the fastest-growing neurological condition globally and dementia cases expected to triple by 2050, Kneu is in a prime position to address these challenges. The traditional care model, often delayed due to limited access to specialists, is no longer sustainable. Patients typically face prolonged waits between visits, leaving them without the necessary support to manage their conditions effectively. Kneu's technology is designed to combat these issues by embedding continuous support directly into daily life and clinical workflows.

A Technological Leap Forward

Kneu's platform is not just innovative; it is backed by more than a decade of rigorous longitudinal research. Utilizing one of the largest datasets for Parkinson's and dementia, the platform generates predictive biomarkers from over 500,000 digital measurements collected from over 1,400 users across NHS and U.S. health systems. By employing clinically trained artificial intelligence models, Kneu will analyze key indicators such as speech, movement, and cognitive function to stratify risk and recommend timely interventions.

The FDA has cleared Kneu's smartphone application specifically for measuring Parkinson's tremors, highlighting its potential to drive proactive monitoring in a way that is accessible and effective for both patients and clinicians. Reports indicate that clinicians have observed improved patient outcomes, including faster access to treatments and significant improvements in self-management capabilities among patients.

Demonstrating Impact and Efficiency

NHS pilot programs reveal compelling evidence of Kneu's effectiveness, showing a 30% boost in patient care efficiency, a notable reduction in preventable emergency admissions, and enhanced planning of Parkinson's care. For instance, Kneu enabled healthcare providers to save approximately 1,000 bed days in a single provider facility, emphasizing the operational and economic benefits of this advanced technology.

Shaping the Future of Neurological Care

Caroline Cake, Kneu's co-founder and CEO, remarked on the significance of the funding at this critical juncture for the healthcare industry, with many systems ready to move beyond temporary fixes to incorporate continuous neurological care as fundamental to patient care. Kneu's first contracts are already underway with reputable institutions like Cedars-Sinai and Mass General Brigham, signaling a promising start to their expansion into the U.S. healthcare market.

Transforming Clinical Approaches

Experts are excited about Kneu's potential to provide reliable, longitudinal insights that can be integrated seamlessly within existing clinical workflows. Joel Schoppig, Health Tech Investment Principal at Oxford Science Enterprises, emphasizes that Kneu has effectively turned everyday smartphone interactions into a trusted measurement layer. This capability alleviates the burden on specialists by prioritizing the most critical cases for in-person consultations.

Nirdesh Gupta, Managing Director of Cedars-Sinai Technology Ventures, highlights Kneu's rigorous application of scientific principles to everyday practice. This reliable signaling between appointments will enhance focus on essential cases, reducing unnecessary visits and optimizing the use of healthcare resources.

Conclusion

Kneu Health stands at the forefront of a much-needed transformation in neurology care, combining innovative technology with evidence-based methods to provide better outcomes for patients with Parkinson's and dementia. As Kneu prepares to broaden its reach, the company is set to play a vital role in redefining how care is delivered to individuals facing neurodegenerative disorders. Learn more about Kneu Health and its groundbreaking initiatives at kneuhealth.com.